| scholarly article | Q13442814 |
| P2093 | author name string | Haak T | |
| Schreiber SA | |||
| P2860 | cites work | Randomized, controlled trials, observational studies, and the hierarchy of research designs | Q24670544 |
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| A comparison of observational studies and randomized, controlled trials | Q33906423 | ||
| A rational approach to drug therapy of type 2 diabetes mellitus | Q33993685 | ||
| Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus | Q34906478 | ||
| Insulin glargine: an updated review of its use in the management of diabetes mellitus | Q35194343 | ||
| Basal insulin supplementation in type 2 diabetes; refining the tactics | Q35687859 | ||
| Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial | Q44479625 | ||
| A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 Diabetes | Q53862758 | ||
| P433 | issue | 1 | |
| P921 | main subject | patient | Q181600 |
| insulin glargine | Q417317 | ||
| type 2 diabetes | Q3025883 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 31-38 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
| P1476 | title | Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients. | |
| P478 | volume | 9 |
| Q34565168 | A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. |
| Q98288263 | Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study |
| Q27009355 | Common standards of basal insulin titration in type 2 diabetes |
| Q37281598 | Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus |
| Q51330863 | Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy. |
| Q30558739 | Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index |
| Q37577129 | How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment |
| Q37087031 | Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study |
| Q37597568 | Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis |
| Q33610830 | Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond |
| Q36947990 | Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence |
| Q34449820 | Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value. |
| Q37199311 | Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience |
| Q37199318 | Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine |
| Q90528673 | Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world |
| Q44615064 | Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations. |
| Q36432159 | Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice |
| Q51297302 | Status of basal-supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti-diabetic drugs. |
| Q37107135 | Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis |
Search more.